Circulating Tumor Cells: Finding Rare Events for A Huge Knowledge of Cancer Dissemination
| Circulating Tumor Cells: Finding Rare Events for A Huge Knowledge of Cancer Dissemination |
| Autore | Alix-Panabieres Catherine |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (366 p.) |
| Soggetto topico | Medicine and Nursing |
| Soggetto non controllato |
abiraterone
ACCEPT androgen receptor AR AR-V7 ARV7 biomarker biomarkers bone marrow breast cancer castration resistant prostate cancer (CRPC) CD133 CellSearch CellSearch® cerebrospinal liquid biopsy chemoradioresistance chromogranin A circulating leukemia cells circulating plasma cells circulating tumor cells circulating tumor cells (CTC) circulating tumor cells (CTCs) circulating tumor DNA circulating tumour cells clinical trials clinical utility colorectal cancer colorectal surgery CTC CTC biology CTC capture technology CTC-based treatment decisions CTC-derived ex vivo models CTC-derived xenografts CTCs ctDNA CTM CTMat ctRNA disseminated tumor cells early breast cancer EasyCount slides emboli enrichment and detection technologies enzalutamide EpCAM enrichment EPISPOT epithelial-mesenchymal transition epithelial-to-mesenchymal transition (EMT) exosome exosomes fibronectin fish flow cytometry FOLFIRINOX gene expression analysis glioma hematological cells hepatocellular carcinoma (HCC) heterogeneity HMB-45 immune checkpoint inhibitors immune system immunofluorescence imaging immunomodulation immunophenotyping in vivo flow cytometry integrin B1 leukocyte-derived extracellular vesicles liquid biopsy liquid surgery locally advanced rectal cancer major histocompatibility complex class I (MHCI) malaria melanoma metastasis metastatic colorectal cancer microbiome microfluidics microsatellite instability miRNA n/a neutrophils NSCLC PD-L1 expression platelets prostate cancer prostate cancer (PCa) RAD23B rovalpituzumab tesirine rVAR2 single-cell analysis SLUG small-cell lung carcinoma solid cancers stem cells synaptophysin targeted therapy thymidylate synthase tumor biomarkers tumor cell dissemination tumor stem cells tumor-initiating cells (TICs) xenograft models |
| ISBN | 3-03928-699-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Circulating Tumor Cells |
| Record Nr. | UNINA-9910404091403321 |
Alix-Panabieres Catherine
|
||
| MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Targeting STAT3 and STAT5 in Cancer
| Targeting STAT3 and STAT5 in Cancer |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (578 p.) |
| Soggetto topico |
Biology, life sciences
Research & information: general |
| Soggetto non controllato |
ADAM17
adoptive T cell therapy AKT androgens apoptosis autoimmune disease autosomal-dominant hyper IgE syndrome Bone Marrow Failure Syndromes breast cancer cancer cancer models cancer progression cancer-stem cell CD38 CD4+ T cells CD8+ T cells cell cycle cell hierarchy chaperones chemotherapy resistance cirrhosis colon cancer companion animals comparative oncology cytokine cytokine receptor signaling dynamic programming endoplasmic reticulum (ER) stress epidermal growth factor receptor (EGF-R) ERK1/2 escape mechanisms gain-of-function mutation glioblastoma glioma growth hormone insensitivity syndrome heat shock proteins hedging hematopoietic cancers hepatitis C virus (HCV) hepatocellular carcinoma (HCC) hepatocyte nuclear factor 4 alpha (HNF4A) immune check point immune suppression immunosuppression immunotherapy inflammation inflammation associated cancer inflammatory hepatocellular adenomas interleukin-6 JAK JAK family of protein tyrosine kinases JAK2 V617F knockout lipopolyplex lung cancer lymphocytes lymphoma M2 macrophages melanoma meta-analysis metalloprotease metastasis microRNA-122 (miR-122) mitochondria MPN mTOR multiple myeloma mutations myeloid cells myeloid leukemia n/a nanoparticle neoplastic stem cells NGS NK cells nuclear factor erythroid 2-related factor 2 (NRF2) nuclear pore complex nuclear transport receptors nucleocytoplasmic shuttling ovarian cancer oxidative stress (OS) PD-L1 PEI pharmacological inhibitor pharmacological inhibitors polyethylenimine post-decision state variable prolactin proliferation prostate cancer RHOA risk management S3I-1757 SH2 domain shedding signal transducer and activator of transcription signal transducer and activator of transcription 3 (STAT3) siRNA delivery siRNA/RNAi small-molecule inhibitors solid cancers stabilization STAT STAT transcription factors STAT3 STAT3 inhibitor XIII STAT5 STAT5 signaling STAT5B signaling stem/progenitor cells stemness T-cell large granular lymphocytic leukemia T-cell leukemia T-cell prolymphocytic leukemia T-cells T-PLL targeted therapy targeting therapeutic targeting therapy resistance trans-signaling transaction costs tumor microenvironment tumor necrosis factor alpha (TNFα) tumor suppression tumor-associated macrophages tumor-immune cell interactions tumorigenesis tyrosine kinase 2 unfolded protein response (UPR) |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557623503321 |
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||